Literature DB >> 11642543

Low-density lipoprotein receptor family: endocytosis and signal transduction.

Y Li1, J Cam, G Bu.   

Abstract

The low-density lipoprotein receptor (LDLR) family is composed of a class of single transmembrane glycoproteins, generally recognized as cell surface endocytic receptors, which bind and internalize extracellular ligands for degradation by lysosomes. Structurally, members of the LDLR family share homology within their extracellular domains, which are highlighted by the presence of clusters of ligand-binding repeats. Recently, information regarding the structural and functional elements within their cytoplasmic tails has begun to emerge, which suggests that members of the LDLR family function not only in receptor-mediated endocytosis, but also in transducing signals that are important during embryonic development and the pathogenesis of Alzheimer's disease. This review focuses on recent knowledge of the structural and functional aspects of LDLR family members in endocytosis and signal transduction. The relationship of these functions to the development of the neuronal system and in the pathogenesis of Alzheimer's disease is specifically discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642543     DOI: 10.1385/MN:23:1:53

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  103 in total

1.  Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis.

Authors:  Y Li; P van Kerkhof ; M P Marzolo; G J Strous; G Bu
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Reelin binds alpha3beta1 integrin and inhibits neuronal migration.

Authors:  L Dulabon; E C Olson; M G Taglienti; S Eisenhuth; B McGrath; C A Walsh; J A Kreidberg; E S Anton
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

3.  Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

Authors:  J C Lambert; F Wavrant-De Vrièze; P Amouyel; M C Chartier-Harlin
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

Review 4.  Mechanisms of Wnt signaling in development.

Authors:  A Wodarz; R Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

5.  Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.

Authors:  Y Du; K R Bales; R C Dodel; X Liu; M A Glinn; J W Horn; S P Little; S M Paul
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

Review 6.  Signal-dependent membrane protein trafficking in the endocytic pathway.

Authors:  I S Trowbridge; J F Collawn; C R Hopkins
Journal:  Annu Rev Cell Biol       Date:  1993

Review 7.  The mammalian low-density lipoprotein receptor family.

Authors:  M M Hussain; D K Strickland; A Bakillah
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

Review 8.  Role of reelin in the control of brain development.

Authors:  T Curran; G D'Arcangelo
Journal:  Brain Res Brain Res Rev       Date:  1998-05

9.  Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

Authors:  A Liao; R M Nitsch; S M Greenberg; U Finckh; D Blacker; M Albert; G W Rebeck; T Gomez-Isla; A Clatworthy; G Binetti; C Hock; T Mueller-Thomsen; U Mann; K Zuchowski; U Beisiegel; H Staehelin; J H Growdon; R E Tanzi; B T Hyman
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

10.  Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease.

Authors:  E Hollenbach; S Ackermann; B T Hyman; G W Rebeck
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  44 in total

1.  The role of Vldlr in intraretinal angiogenesis in mice.

Authors:  Chun-Hong Xia; Eric Lu; Haiquan Liu; Xin Du; Bruce Beutler; Xiaohua Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-22       Impact factor: 4.799

Review 2.  LRP receptor family member associated bone disease.

Authors:  N Lara-Castillo; M L Johnson
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

3.  Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

4.  A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.

Authors:  Patrick Poulin
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

5.  Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.

Authors:  Yuji Kajiwara; Sonia Franciosi; Nagahide Takahashi; Lisa Krug; James Schmeidler; Kevin Taddei; Vahram Haroutunian; Ulrik Fried; Michelle Ehrlich; Ralph N Martins; Samuel Gandy; Joseph D Buxbaum
Journal:  Mol Neurodegener       Date:  2010-01-14       Impact factor: 14.195

6.  Determining Cell-surface Expression and Endocytic Rate of Proteins in Primary Astrocyte Cultures Using Biotinylation.

Authors:  Daniel Kai Long Tham; Hakima Moukhles
Journal:  J Vis Exp       Date:  2017-07-03       Impact factor: 1.355

7.  The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing.

Authors:  Claus U Pietrzik; Tracy Busse; David E Merriam; Sascha Weggen; Edward H Koo
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

8.  Differential regulation of CXCR2 trafficking by Rab GTPases.

Authors:  Guo-Huang Fan; Lynne A Lapierre; James R Goldenring; Ann Richmond
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

9.  Engulfment adaptor phosphotyrosine-binding-domain-containing 1 (GULP1) is a nucleocytoplasmic shuttling protein and is transactivationally active together with low-density lipoprotein receptor-related protein 1 (LRP1).

Authors:  Anke Wahler; Anja-Silke Beyer; Ilona E Keller; Cathrin Schnack; Björn von Einem; Christian Pröpper; Tobias M Boeckers; Ithan D Peltan; Dudley K Strickland; Bradley T Hyman; Christine A F von Arnim
Journal:  Biochem J       Date:  2013-03-01       Impact factor: 3.857

10.  Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking.

Authors:  Rodrigo A Fuentealba; Qiang Liu; Juan Zhang; Takahisa Kanekiyo; Xiaoyan Hu; Jin-Moo Lee; Mary Jo LaDu; Guojun Bu
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.